Profiel
Andy Crew worked as a Senior Director at OSI Pharmaceuticals and Astellas Pharmaceuticals SA from 2002 to 2013.
He was also a Principal Scientist at Knoll Pharmaceutical Co. from 1990 to 1996.
Later, he worked as a Senior Vice President-Chemistry at Arvinas Operations, Inc. and Arvinas, Inc. from an unknown date to 2019.
Dr. Crew holds a doctorate degree from The University of Liverpool.
Eerdere bekende functies van Andy Crew
| Bedrijven | Functie | Einde |
|---|---|---|
| OSI PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-01-2013 |
Astellas Pharmaceuticals SA | Directeur/Bestuurslid | 01-01-2013 |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | 01-01-1996 |
| ARVINAS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Corporate Officer/Principal | - |
Opleiding van Andy Crew
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Astellas Pharmaceuticals SA | |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
















